Centum Electronics (517544) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
25 Oct, 2026Executive summary
Consolidated Q1 FY26 revenue was ₹2,734m, up 11.4% YoY; EBITDA rose 46.8% to ₹229m, with an 8.38% margin.
Standalone revenue grew 35% to ₹1,796m; PAT was ₹165m and EBITDA margin was 14.92%.
Order book reached ₹17,691m at June 30, 2025, supported by EMS serial-production programs and new DRDO development orders.
Financial highlights
Consolidated PAT was ₹44.76m versus a loss of ₹38.43m in Q1 FY25; PAT margin improved to 1.65%.
Standalone EBITDA was ₹268m, up over 100% YoY; standalone PAT was ₹165m, up over 250%.
Sale of products and services revenue was ₹2,635.05m; total income was ₹2,763.39m.
Consolidated results included a ₹17.65m exceptional reversal related to Ausar.
Outlook and guidance
Medium-term consolidated revenue growth objective is 18%-20%; standalone growth is expected to be higher, with EMS and Build-to-Spec each targeted to grow at 25%+.
Consolidated EBITDA margin objective is 13%-15%; subsidiary margins are targeted to improve from ~1% to 10%-11% in two years.
Subsidiary performance is expected to improve in H2 FY26, subject to conversion of Defence and Aerospace opportunities; ER&D performance also depends on opportunity conversion.
Healthy order booking is expected, while large government programs remain subject to approval processes and are not expected in the very short term.
Latest events from Centum Electronics
- Q2 revenue rose 52% YoY as the order book reached Rs 19.5 billion.517544
Q2 26/27 - Adjusted revenue grew 7%; H2 BTS deliveries are expected to support recovery.517544
Q1 24/25 - FY25 targets rely on a stronger H2 led by BTS delivery and subsidiary performance.517544
Q2 24/25 - Ausar provision and Canadian losses weighed on consolidated results despite standalone growth.517544
Q3 24/25 - Q4 margins rebounded as the order book supported FY26 growth targets despite subsidiary losses.517544
Q4 24/25 - Standalone growth strengthened, while subsidiary losses constrained consolidated margins.517544
Q2 25/26 - Standalone growth and defense prospects offset overseas restructuring losses and impairments.517544
Q3 25/26 - Revenue and order growth were offset by overseas restructuring losses.517544
Q4 25/26 - Order book rose 31% as Q1 margins softened and reported profit included discontinued operations.517544
Q1 26/27